Healthcare provider profile · identity verified

Mark Alan Harvey, MD

Family Practice · CLACKAMAS, OR · NPI 1619068848

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	394	122
Amlodipine Besylate	Amlodipine Besylate	304	93
Losartan Potassium	Losartan Potassium	246	87
Oxycodone Hcl	Oxycodone Hcl	238	50
Levothyroxine Sodium	Levothyroxine Sodium	231	64
Simvastatin	Simvastatin	226	62
Lisinopril	Lisinopril	213	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	208	50
Metformin Hcl	Metformin Hcl	192	64
Potassium Chloride	Potassium Chloride	189	54
Gabapentin	Gabapentin	185	55
Atenolol	Atenolol	157	52
Trazodone Hcl	Trazodone Hcl	157	51
Tamsulosin Hcl	Tamsulosin Hcl	156	52
Albuterol Sulfate Hfa	Albuterol Sulfate	127	50
Metoprolol Tartrate	Metoprolol Tartrate	118	41
Fluoxetine Hcl	Fluoxetine Hcl	110	29
Allopurinol	Allopurinol	109	32
Hydrochlorothiazide	Hydrochlorothiazide	105	36
Furosemide	Furosemide	101	39
Pradaxa	Dabigatran Etexilate Mesylate	100	34
Omeprazole	Omeprazole	96	32
Glipizide	Glipizide	92	29
Pravastatin Sodium	Pravastatin Sodium	91	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	27
Lovastatin	Lovastatin	79	22
Pantoprazole Sodium	Pantoprazole Sodium	76	35
Clopidogrel	Clopidogrel Bisulfate	75	22
Buspirone Hcl	Buspirone Hcl	72	18
Duloxetine Hcl	Duloxetine Hcl	72	23
Meloxicam	Meloxicam	71	33
Metoprolol Succinate	Metoprolol Succinate	68	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	22
Tizanidine Hcl	Tizanidine Hcl	66	21
Prednisone	Prednisone	65	26
Metformin Hcl Er	Metformin Hcl	64	21
Venlafaxine Hcl Er	Venlafaxine Hcl	56	18
Ondansetron Odt	Ondansetron	55	19
Famotidine	Famotidine	54	17
Warfarin Sodium	Warfarin Sodium	54	18
Oxazepam	Oxazepam	53	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	53	18
Spironolactone	Spironolactone	52	15
Alendronate Sodium	Alendronate Sodium	49	22
Bisoprolol Fumarate	Bisoprolol Fumarate	47	14
Mirtazapine	Mirtazapine	46	14
Sertraline Hcl	Sertraline Hcl	46	14
Carvedilol	Carvedilol	45	13
Topiramate	Topiramate	44	13
Rosuvastatin Calcium	Rosuvastatin Calcium	42	16
Bupropion Xl	Bupropion Hcl	41	15
Finasteride	Finasteride	41	15
Humulin N	Insulin Nph Human Isophane	41	14
Pregabalin	Pregabalin	41	14
Lorazepam	Lorazepam	40	19
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	18
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Donepezil Hcl	Donepezil Hcl	38	13
Escitalopram Oxalate	Escitalopram Oxalate	38	17
Celecoxib	Celecoxib	36	suppressed
Propranolol Hcl	Propranolol Hcl	36	13
Triamcinolone Acetonide	Triamcinolone Acetonide	36	27
Alvesco	Ciclesonide	35	12
Clonazepam	Clonazepam	34	suppressed
Acyclovir	Acyclovir	32	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	14
Hydrocortisone	Hydrocortisone	32	16
Torsemide	Torsemide	32	12
Spiriva Respimat	Tiotropium Bromide	31	14
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	31	suppressed
Diazepam	Diazepam	30	suppressed
Ibuprofen	Ibuprofen	29	12
Terazosin Hcl	Terazosin Hcl	27	suppressed
Codeine Sulfate	Codeine Sulfate	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	14
Ketoconazole	Ketoconazole	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Morphine Sulfate	Morphine Sulfate	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	22	suppressed
Fluoridex	Fluoride (Sodium)	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Nystatin	Nystatin	21	12
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Felodipine Er	Felodipine	20	suppressed
Eliquis	Apixaban	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Ozempic	Semaglutide	19	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	19	18
Estradiol	Estradiol	18	suppressed
Fluconazole	Fluconazole	18	11
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Naproxen	Naproxen	18	suppressed
Jardiance	Empagliflozin	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Digoxin	Digoxin	16	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	16	suppressed
Colchicine	Colchicine	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Baclofen	Baclofen	14	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	14	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Dapsone	Dapsone	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	11
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	12	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed
Verapamil Hcl	Verapamil Hcl	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error